Abstract
ABSTRACTPrecision medicine is critically dependent on better methods for diagnosing and staging disease and predicting drug response. Histopathology using Hematoxylin and Eosin (H&E) stained tissue - not genomics – remains the primary diagnostic method in cancer. Recently developed highly-multiplexed tissue imaging methods promise to enhance research studies and clinical practice with precise, spatially-resolved, single-cell data. Here we describe the “Orion” platform for collecting and analyzing H&E and high-plex immunofluorescence (IF) images from the same cells in a whole-slide format suitable for diagnosis. Using a retrospective cohort of 74 colorectal cancer resections, we show that IF and H&E images provide human experts and machine learning algorithms with complementary information that can be used to generate interpretable, multiplexed image-based models predictive of progression-free survival. Combining models of immune infiltration and tumor-intrinsic features achieves a hazard ratio of ∼0.05, demonstrating the ability of multi-modal Orion imaging to generate high-performance biomarkers.
Publisher
Cold Spring Harbor Laboratory
Reference87 articles.
1. Bock, O . A history of the development of histology up to the end of the nineteenth century. Research (2015).
2. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.
3. Immunological Properties of an Antibody Containing a Fluorescent Group.
4. Robbins & C otran pathologic basis of disease. (Elsevier, 2021).
5. Demir, C. & Yener, B. Automated cancer diagnosis based on histopathological images: A systematic survey. (2004).